The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma

In recent years, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced as a therapeutic option in the treatment of several congenital and acquired craniofacial defects. Although there have been promising clinical results, the international literature still lacks complete guide...

Full description

Bibliographic Details
Main Author:	A.S. Herford
Format:	Article
Language:	English
Published:	Elsevier 2017-02-01
Series:	Chinese Journal of Traumatology
Subjects:	Recombinant human bone morphogenetic protein-2 Maxillofacial trauma Clinical application
Online Access:	http://www.sciencedirect.com/science/article/pii/S1008127516301523

id	doaj-8989807ea01a43178e85bc9a61b2b727
record_format	Article
spelling	doaj-8989807ea01a43178e85bc9a61b2b7272020-11-24T22:04:14ZengElsevierChinese Journal of Traumatology1008-12752017-02-012011310.1016/j.cjtee.2016.05.004The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial traumaA.S. HerfordIn recent years, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced as a therapeutic option in the treatment of several congenital and acquired craniofacial defects. Although there have been promising clinical results, the international literature still lacks complete guidelines, including limits and indications for the use of rhBMP-2. The possible indications for rhBMP-2 in patients undergoing facial trauma are discussed in this article.http://www.sciencedirect.com/science/article/pii/S1008127516301523Recombinant human bone morphogenetic protein-2Maxillofacial traumaClinical application
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	A.S. Herford
spellingShingle	A.S. Herford The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma Chinese Journal of Traumatology Recombinant human bone morphogenetic protein-2 Maxillofacial trauma Clinical application
author_facet	A.S. Herford
author_sort	A.S. Herford
title	The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
title_short	The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
title_full	The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
title_fullStr	The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
title_full_unstemmed	The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
title_sort	use of recombinant human bone morphogenetic protein-2 (rhbmp-2) in maxillofacial trauma
publisher	Elsevier
series	Chinese Journal of Traumatology
issn	1008-1275
publishDate	2017-02-01
description	In recent years, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced as a therapeutic option in the treatment of several congenital and acquired craniofacial defects. Although there have been promising clinical results, the international literature still lacks complete guidelines, including limits and indications for the use of rhBMP-2. The possible indications for rhBMP-2 in patients undergoing facial trauma are discussed in this article.
topic	Recombinant human bone morphogenetic protein-2 Maxillofacial trauma Clinical application
url	http://www.sciencedirect.com/science/article/pii/S1008127516301523
work_keys_str_mv	AT asherford theuseofrecombinanthumanbonemorphogeneticprotein2rhbmp2inmaxillofacialtrauma AT asherford useofrecombinanthumanbonemorphogeneticprotein2rhbmp2inmaxillofacialtrauma
_version_	1725829755629993984

The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma

Similar Items